I was inspired to go to college by my parents, who were children of the Great Depression and did not have the financial resources to attend college themselves. In medical school and residency, my mentor physicians encouraged me to choose infectious diseases as a subspecialty.
As an infectious disease physician and director of Adult Clinical Services, I treat each patient as I would want to be treated. Infectious Disease is a small division, so we work closely with our nurses and medical assistants to provide timely and exceptional patient care.
I received the Centers for Disease Control and Prevention Immunization Champion Award for the state of Ohio in 2018. This award was for my efforts in improving immunization rates among Ohio’s children.
In my research, my colleagues and I are looking for ways to improve vaccines for influenza. We are also studying candidate vaccines for SARS-CoV-2, which is the cause of COVID-19 disease.
During my spare time, I enjoy embroidery, and I make my own clothes.
MD: University of Kentucky, Lexington, KY, 1988.
Residency: Internal Medicine/Pediatrics, University of Louisville, Louisville, KY.
Fellowships: Pediatric Infectious Diseases, Children's Hospital Medical Center, Cincinnati, Ohio; Adult Infectious Diseases, University of Cincinnati, Cincinnati, OH.
Certifications: Pediatrics, 1992, recertified 1999; Internal Medicine, 1993; Pediatric Infectious Diseases, 1997; Adult Infectious Diseases, 1997.
Adult and pediatric infectious disease
Infectious Diseases
Cytomegalovirus and other viral infections
Infectious Diseases
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum. The Pediatric Infectious Disease Journal. 2024; 43:1065-1073.
How Sensitive and Specific Are the Office-Based Rapid Respiratory Syncytial Virus and Rapid Influenza Tests?. Curbside Consultation in Pediatric Infectious Disease. : Taylor & Francis; Taylor & Francis; 2024.
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants. Pediatrics. 2024; 153:e2023064252.
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial. The Journal of Infectious Diseases. 2024; 229:327-340.
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants. npj Vaccines. 2023; 8:98.
462. Infant antibody titers at birth following maternal COVID-19 vaccination and protection against infection in the first 6 months of life. Open Forum Infectious Diseases. 2023; 10:ofad500.532.
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn. Vaccine. 2023; 41:5296-5303.
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults. The Journal of Infectious Diseases. 2023; 228:287-298.
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. Cell Reports Medicine. 2022; 3:100679.
Homologous and Heterologous Covid-19 Booster Vaccinations. The New England Journal of Medicine. 2022; 386:1046-1057.
Rebecca C. Brady, MD, Robert W. Frenck Jr., MD7/21/2022
Rebecca C. Brady, MD, Robert W. Frenck Jr., MD1/26/2022
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey